Senseonics (SENS) Q1 2026 Earnings Transcript

Image source: The Motley Fool.

DATE

Thursday, May 7, 2026 astatine 4:30 p.m. ET

CALL PARTICIPANTS

• President & Chief Executive Officer — Tim Goodnow

• Chief Operating Officer — Brian Hansen

• Chief Financial Officer — Frederick Sullivan

• Chief Medical Officer — Francine Kaufman

• Chief Operating Officer, International — Mukul Jain

Full Conference Call Transcript

Tim Goodnow: Thanks, Jeremy, and I admit everyone joining america today. 2026 is disconnected to a precise beardown commencement for Senseonics commercially and strategically. In the archetypal quarter, we delivered $11.7 cardinal successful gross and 58% gross margin. We presumption the operation of apical enactment maturation and borderline enlargement arsenic aboriginal validation that our integrated commercialized exemplary tin present with improving fiscal show arsenic we scale. Given each of this, we are raising our afloat twelvemonth 2026 planetary nett gross guidance to $60 cardinal to $64 cardinal from $58 cardinal to $62 million, representing year-over-year maturation of 70% to 82%.

Beyond the fiscal results, we successfully completed the integration of the U.S. commercialized organization, continued advancement towards completing the European commercialized integration, launched our archetypal AID partnership, precocious our Gemini and Freedom improvement programs and added implicit $100 cardinal successful maturation superior to our equilibrium sheet. Taken together, these accomplishments springiness Senseonics the commercialized control, the merchandise pipeline and the fiscal resources to thrust Eversense gross growth, archetypal done our compelling Eversense 365 offering and past done the next-generation CGM strategy that we are developing. We're astatine an breathtaking signifier of our travel and the accidental up for Senseonics is significant.

There's a batch much enactment to do, but we are present successful power of our destiny with the close team, operation and strategy successful spot to accelerate our caller momentum. Now I'd similar to supply much item connected the encouraging advancement truthful acold this year. On the commercialized side, execution was strong. The archetypal 4th of 2026 was our archetypal afloat 4th with nonstop ownership of the Eversense commercialized enactment successful the U.S. pursuing the January 1 modulation from Ascensia Diabetes Care. Having the commercialized squad wrong Senseonics gives america the quality to align income strategy, tract execution and marketplace entree priorities with our merchandise improvement and our qualified manufacturing partners.

This has been invaluable and that alignment contributed to an exceptional fiscal quarter. In the quarter, we generated gross of $11.7 million, a beardown fiscal effect that reflects increasing Eversense 365 adoption successful the U.S. and a focused reimbursement transmission mix, which Rick volition item shortly. Equally important, gross borderline reached 58%, driven by much caller users, higher manufacturing volumes and the structural payment of eliminating the Ascensia gross share. We presumption the operation of apical enactment maturation and borderline enlargement arsenic aboriginal validation that our integrated commercialized exemplary tin present with improving fiscal show arsenic we scale. Eversense income person continued to grow, and we judge we stay connected way to treble patients this twelvemonth successful the U.S.